Group One Trading’s NRX Pharmaceuticals NRXP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $10.1K | Buy |
+3,108
| New | +$10.1K | ﹤0.01% | 1571 |
|
2025
Q1 | – | Sell |
-99
| Closed | -$218 | – | 3047 |
|
2024
Q4 | $218 | Buy |
+99
| New | +$218 | ﹤0.01% | 1906 |
|
2024
Q2 | – | Sell |
-91
| Closed | -$428 | – | 2677 |
|
2024
Q1 | $428 | Sell |
91
-1,825
| -95% | -$8.58K | ﹤0.01% | 1616 |
|
2023
Q4 | $8.81K | Hold |
1,916
| – | – | ﹤0.01% | 1437 |
|
2023
Q3 | $4.98K | Sell |
1,916
-570
| -23% | -$1.48K | ﹤0.01% | 1516 |
|
2023
Q2 | $12K | Buy |
2,486
+353
| +17% | +$1.71K | ﹤0.01% | 1281 |
|
2023
Q1 | $14.1K | Sell |
2,133
-2,517
| -54% | -$16.6K | ﹤0.01% | 1263 |
|
2022
Q4 | $51.6K | Sell |
4,650
-6,708
| -59% | -$74.5K | ﹤0.01% | 1080 |
|
2022
Q3 | $84K | Sell |
11,358
-5,934
| -34% | -$43.9K | ﹤0.01% | 1057 |
|
2022
Q2 | $104K | Buy |
17,292
+13,903
| +410% | +$83.6K | ﹤0.01% | 1059 |
|
2022
Q1 | $83K | Buy |
3,389
+2,763
| +441% | +$67.7K | ﹤0.01% | 1291 |
|
2021
Q4 | $30K | Sell |
626
-131
| -17% | -$6.28K | ﹤0.01% | 1702 |
|
2021
Q3 | $70K | Buy |
+757
| New | +$70K | ﹤0.01% | 1451 |
|